BDBM314403 US9611249, Compound 34::[4-({[(5-cyclohexyl-1H-indazol-3-yl) carbonyl]amino}methyl)piperidin-1-yl] acetic acid
SMILES: OC(=O)CN1CCC(CNC(=O)c2n[nH]c3ccc(cc23)C2CCCCC2)CC1
InChI Key: InChIKey=BGMLEHXLZHSVAW-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glycogen synthase kinase-3 beta (Homo sapiens (Human)) | BDBM314403 (US9611249, Compound 34 | [4-({[(5-cyclohexyl-1H-in...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.07E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. US Patent | Assay Description Activity on human GSK-3β was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screen... | US Patent US9611249 (2017) BindingDB Entry DOI: 10.7270/Q2JH3P79 | |||||||||||
More data for this Ligand-Target Pair |